Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dietmar13
    Senior Member
    • Mar 2010
    • 107

    #1

    BBMap for BitSeq

    Hello,

    I want use BBmap for estimating transcript expression level from RNA-seq reads. Mapped will be against transcripts, not the genome.

    The Manual for BitSeq uses Bowtie with following conditions:

    Code:
    bowtie -q -v 3 -3 0 -p 4 -a -m 100 --sam
    3 mismatches allowed
    no 3' trimming (and no 5' trimming) - both default
    report reads only if < 100 possible mapping positions


    how should the BBmap parameters look like?

    Code:
    bbmap.sh ambiguous=all maxsites2=100 ( secondary=TRUE sssr=0.95 maxsites=100 )
    is there a parameter for allowed mismatches per read?
    will "secondary=TRUE sssr=0.95 maxsites=100" be a good idea for mapping reads to the human transcriptome. sssr=0.95 means approximate how many mismatches per 75 bases reads ~ 2?

    should the reads be trimmed and quality filtered before, and if yes with which parameters?

    Dietmar
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    I imagine the main reason for specifying 3 mismatches with Bowtie is that 3 is the maximum it allows.

    BBMap normally adjusts sensitivity with the mind/minratio parameter, though you can optionally set "subfilter=3" to ban alignments with more than 3 substitutions. I don't see how that would be beneficial to transcriptome mapping, though.

    I would suggest:

    "bbmap.sh (file parameters) ambig=all maxsites=100 maxindel=100"

    ...and if you really want, add "subfilter=3". For transcriptome mapping there's no reason to allow the default maxindel=16000. And there is not much need to apply any quality-trimming or filtering unless you add the "subfilter" flag and have low-quality data, though you can do that if you want with "qtrim=rl trimq=10" to trim both ends to Q10. I do, however, always recommend adapter-trimming, particularly when requiring high-identity alignments.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...